Source: Eur Respir J 2007; 30: 321-332
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Diel R., Wrighton-Smith P., Zellweger J-P.. Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis. Eur Respir J 2007; 30: 321-332

Member's Comments

No comment yet.

Related content which might interest you: Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test Source: Eur Respir J 2006; 28: 16-23 Year: 2006 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010 Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI) Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection Source: Eur Respir J 2010; 35: 619-626 Year: 2010 Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting? Source: Eur Respir J 2011; 38: 649-656 Year: 2011 Cost-effectiveness of two latent tuberculosis infection screening strategies Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 New immunologic tools for the diagnosis and therapy of tuberculosis Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005